Mon. 6 May 2024, 4:03pm ET
Benzinga
Earnings, Earnings Beats, News
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.69) by 4.35 percent. This is a 9.59 percent increase over losses of $(0.73) per share from the same period last year.